Cargando…
258. False Negative Rate of T2Candida Assay in Blood Culture Positive Candidemia
BACKGROUND: The T2Candida (T2C) assay is an FDA-approved, non-culture-based rapid diagnostic that utilizes PCR and magnetic resonance technology to detect candidemia in a whole blood specimen. T2C can detect the 5 most common pathogenic species: C. albicans, C. tropicalis, C. parapsilosis, C. krusei...
Autores principales: | McCarty, Todd, Leal, Sixto M, Lee, Rachael A, White, Cameron, Pappas, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810022/ http://dx.doi.org/10.1093/ofid/ofz360.333 |
Ejemplares similares
-
248. Thirty-Day Mortality Among Patients with Candidemia Diagnosed by T2Candida Assay Alone: Influence of Risk Factors and Candida Species
por: White, Cameron, et al.
Publicado: (2019) -
1173. Ocular Candidiasis in Patients with Candidemia Diagnosed by Blood Culture Versus T2Candida® Assay
por: White, Cameron, et al.
Publicado: (2020) -
Relationship of T2 Candida Panel to Disease Severity, Mortality and Time to Therapy in Patients with Candidemia
por: Turner, Orlando D, et al.
Publicado: (2017) -
The impact of GenMark Dx ePlex blood-culture identification on the treatment and outcomes of gram-positive bacteremia
por: Kiszla, B. Matthew, et al.
Publicado: (2022) -
214. Prospective Evaluation of the GenMark Dx ePlex(®) Blood Culture Identification Gram Negative Panel
por: Meeder, Jeremy, et al.
Publicado: (2021)